Medherant offers rapid evaluation of the suitability of drugs for formulation with its TEPI Patch® technology by determining their compatibility with its adhesives, formulating prototype patches and then testing them against a predetermined target release profile.

We’re able to create a short-list of candidate formulations in 2-3 months with complete proof-of-concept studies and a range of formulations to meet your target product profile using our in-house formulation & small-scale non-GMP manufacturing capability.
Phase 1: Drug compatibility
- Solubility in adhesive
- Analytical methods
- Curing optimisation
Phase 2: Patch formulation & prototyping
- API extraction
- API release
- API permeation
- Adhesion testing
Optional extra work
- Patch stability testing
- Extended release & permeation study
- Additional adhesion testing
- Manufacture for non-clinical studies
- Process development